These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 16200621

  • 21. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
    Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ.
    FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
    [Abstract] [Full Text] [Related]

  • 22. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
    Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, Nakayama T, Yoshie O, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
    [Abstract] [Full Text] [Related]

  • 23. Cancer CXC chemokine networks and tumour angiogenesis.
    Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA.
    Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
    [Abstract] [Full Text] [Related]

  • 24. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.
    Page G, Chevrel G, Miossec P.
    Arthritis Rheum; 2004 Jan; 50(1):199-208. PubMed ID: 14730617
    [Abstract] [Full Text] [Related]

  • 25. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
    Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, Tüting T.
    Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M, Carter S, Hofer MJ, Campbell IL.
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [Abstract] [Full Text] [Related]

  • 29. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J, Van Damme J, Struyf S.
    Cancer Lett; 2008 Aug 28; 267(2):226-44. PubMed ID: 18579287
    [Abstract] [Full Text] [Related]

  • 30. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
    Keane MP, Arenberg DA, Lynch JP, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Strieter RM.
    J Immunol; 1997 Aug 01; 159(3):1437-43. PubMed ID: 9233641
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM, Park JO, Kim D, Kim JY, Oh KH, Park CG, Oh BH, Kim S, Ahn C.
    Xenotransplantation; 2006 Jul 01; 13(4):328-36. PubMed ID: 16768726
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.
    Ruschpler P, Lorenz P, Eichler W, Koczan D, Hänel C, Scholz R, Melzer C, Thiesen HJ, Stiehl P.
    Arthritis Res Ther; 2003 Jul 01; 5(5):R241-52. PubMed ID: 12932287
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Identification, functional analysis and expression in a heterotopic heart transplant model of CXCL9 in the rat.
    Mitsuhashi N, Kearns-Jonker M, Wu GD, Bowdish ME, Jin YS, Mencel R, Zahorsky-Reeves J, Fischer-Lougheed J, Weinberg KI, Starnes VA, Cramer DV.
    Immunology; 2004 May 01; 112(1):87-93. PubMed ID: 15096188
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
    Ulfgren AK, Grundtman C, Borg K, Alexanderson H, Andersson U, Harris HE, Lundberg IE.
    Arthritis Rheum; 2004 May 01; 50(5):1586-94. PubMed ID: 15146429
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D, Crowe P, Zlotnik A, Alleva DG.
    J Pharmacol Exp Ther; 2005 Jun 01; 313(3):1263-71. PubMed ID: 15761110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.